Paperwork Reduction Act Notices
The Paperwork Reduction Act of 1995 establishes a broad mandate for agencies to perform their information collection activities in an efficient, effective, and economical manner. That is, to minimize the time, effort, or financial resources needed by the public to generate, maintain, or provide information to or for the government.
When CVM proposes a rule, drafts a guidance, or conducts a survey, we seek public comment on any new proposed collection of information for 60 days as the first step toward approval for that information collection. We also seek public comment as the first step in the periodic renewal of approval of our existing, approved information collections.
Below are the current “60-day notices” that are available for public comment.
You can submit either electronic or written comments on these notices. Submit electronic comments to http://www.regulations.gov. Submit written comments to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. All comments should be identified with the docket number found in brackets in the heading of the notice.
For further information on any of these notices, please contact the FDA PRA staff at PRAStaff@fda.hhs.gov.
|OMB #||Subject||Comment Period Closing Date|
|0910-0575||Waiver of In Vivo Demonstration of Bioequivalence of Animal Drugs in Soluble Powder Oral Dosage Form Products and Type A Medicated Articles||3/13/2015|